The present disclosure relates to devices, systems, and methods for securing soft tissue to bone, and more particularly it relates to securing an ACL graft to a femur.
Joint injuries may commonly result in the complete or partial detachment of ligaments, tendons, and soft tissues from bone. Tissue detachment may occur in many ways, e.g., as the result of an accident such as a fall, overexertion during a work related activity, during the course of an athletic event, or in any one of many other situations and/or activities. These types of injuries are generally the result of excess stress or extraordinary forces being placed upon the tissues.
In the case of a partial detachment, commonly referred to under the general term “sprain,” the injury frequently heals without medical intervention, the patient rests, and care is taken not to expose the injury to undue strenuous activities during the healing process. If, however, the ligament or tendon is completely detached from its attachment site on an associated bone or bones, or if it is severed as the result of a traumatic injury, surgical intervention may be necessary to restore full function to the injured joint. A number of conventional surgical procedures exist for re-attaching such tendons and ligaments to bone.
One such procedure involves forming aligned femoral and tibial tunnels in a knee to repair a damaged anterior cruciate ligament (“ACL”). In one ACL repair procedure, a ligament graft is associated with a surgical implant and secured to the femur. A common ACL femoral fixation means includes an elongate “button,” sometimes referred to as a cortical button. The cortical button is attached to a suture loop that is sized to allow an adequate length of a soft tissue graft to lie within the femoral tunnel while providing secure extra-cortical fixation.
Existing devices and methods for surgical repairs have a number of limitations. For example, existing devices and methods do not always provide the desired strength. In some instances, one or more knots tied to help maintain a location of the suture loop with respect to a cortical button, and thus the graft associated therewith, can loosen or slip. Thus, even if a ligament graft is disposed at a desired location during a procedure, post-operatively the circumference of the loop can increase, causing the graft to move away from the desired location. The use of knots in conjunction with existing devices and methods can also be undesirable because of the additional surface area they provide, thereby increasing the risk of trauma at the surgical site.
Existing devices and methods also lack adjustability in many instances. For example, in procedures in which multiple ligament grafts are associated with the cortical button, it can be difficult to control placement of one ligament graft without also moving the other ligament graft. Still further, existing devices and methods often posses suture management issues. Many devices and methods use a plurality of sutures or filaments to guide and manipulate the button and associated ligament graft(s) to desired locations. The filaments can become tangled, difficult to identify during the course of a procedure, and cumbersome due to the total volume of filaments disposed in the bone tunnel. Additionally, although at least some of the filaments used to implant the button can be removed after implantation, it can be difficult to remove the filaments. As a result, in some instances, filaments can remain implanted in the body even though they serve no purpose after button implantation. Portions of filaments located at the surgical site can be cut after the button is delivered. To the extent filaments are cut, however, care should be taken to not cut too much of the filament. In some instances, a sleeve can be disposed around a portion of a filament extending from a knot to help indicate to a surgeon where to cut the filament. The sleeve, however, may bunch within the bone tunnel.
Accordingly, it is desirable to provide devices, systems, and methods that improve the strength and adjustability of surgical implants used in conjunction with ligament graft insertion, to minimize the number of knots associated with maintaining a location of the grafts once the grafts are disposed at desired locations, and to make it easy to remove filaments from a surgical site after implantation has occurred.
Devices, systems, and methods are generally provided for performing soft tissue (e.g., ACL) repairs. In one exemplary embodiment, a surgical implant includes an implantable body, an adjustable filament loop coupled to the body, and a shuttle suture removably coupled to the implantable body. The adjustable filament loop can have at least one adjustable limb extending therefrom, and it can be configured to adjust a size of the loop when tension is applied to the limb. The shuttle suture can have at least a portion of it that is hollow, and the at least one adjustable limb can extend from the filament loop, into the hollow portion, and exit out of the shuttle suture at a location that is more remote from the implantable body than a location at which the adjustable limb enters the shuttle suture.
The implantable body can include a plurality of thru-holes formed in it. The adjustable filament loop can be disposed through at least two of the thru-holes, and the shuttle suture can be disposed through at least one of the thru-holes. In some embodiments the thru-hole through which the shuttle suture is disposed can be s different thru-hole than any thru-hole through which the adjustable filament loop is disposed. In some embodiments the adjustable loop can include a plurality of coils formed as a result of suture of the adjustable filament loop being disposed through at least two of the plurality of thru-holes of the body such that a portion of each coil is disposed on the top side of the body and a portion of each coil is disposed on a bottom side of the body.
The adjustable filament loop can include a self-locking knot formed on a top side of the body. In some embodiments the at least one adjustable limb includes a first adjustable limb and a second adjustable limb. The first adjustable limb can extend into a first hollow portion of the shuttle suture, and the second adjustable limb can extend into a second hollow portion of the shuttle suture. The at least one adjustable limb can enter the hollow portion of the shuttle suture at a location such that it is configured to form an acute angle with a longitudinal axis extending through a length of the implantable body.
The shuttle suture can be disposed through a thru-hole formed in the implantable body, and it can be configured to guide the implantable body, and the adjustable loop coupled thereto, through a passageway. In some embodiments the shuttle suture can be configured to bunch in the hollow portion of the shuttle suture when tension is applied to the at least one adjustable limb in a first direction, away from the implantable body, and a force is applied to the shuttle suture in a second, substantially opposite direction, toward the implantable body.
Another exemplary embodiment of a surgical implant includes a body having a plurality of thru-holes formed therein, a first suture filament extending through the body, and a second suture filament removably disposed through a thru-hole of the plurality of thru-holes. The first suture filament can be configured to form a self-locking knot and one or more coils. The self-locking knot can define a collapsible opening. The one or more coils can be arranged such that each coil is formed as a result of the first suture filament being disposed through at least two of the plurality of thru-holes of the body such that a portion of each coil is disposed on the top side of the body and a portion of each coil is disposed on a bottom side of the body. First and second terminal ends of the first suture filament can extend from the self-locking knot, and can be configured to adjust a size of one or more of the coils when tension is applied to one or both of the terminal ends. The second suture filament can have at least a portion of a first limb that is hollow, and at least a portion of a second limb that is hollow. The first terminal end of the first suture filament can be disposed in at least a portion of the hollow portion of the first limb, while the second terminal end of the first suture filament can be disposed in at least a portion the hollow portion of the second limb.
A location at which each of the first and second terminal ends of first suture filament exit the second suture filament can be more remote from the body of the implant than a location at which the terminal ends entered the second suture filament when tension is applied to the second suture filament. The first terminal end can enter a portion of the hollow portion of the first limb at a location such that it forms an acute angle with a longitudinal axis extending through a length of the body, and the second terminal end can enter a portion of the hollow portion of the second limb at a location such that it forms an acute angle with the longitudinal axis extending through the length of the body.
The second suture filament can be configured to bunch in the hollow portions when tension is applied to the first and second terminal ends in a first direction, away from the body, and a force is applied to the second suture filament in a second, substantially opposite direction, toward the body. In some embodiments a thru-hole through which the second suture filament is disposed can be a different thru-hole than the at least two thru-holes through which the first filament is disposed. In some embodiments the thru-hole through which the second suture filament is disposed can be an end thru-hole. A vertical distance between the top side of the body and a location at which the first one of the first and second terminal ends enters the second suture can be in the range of about 5 millimeters to about 50 millimeters. A length of at least one of the first and second terminal ends disposed in the hollow portion of the second filament can be in the range of about 10 millimeters to about 100 millimeters.
One exemplary embodiment of a surgical method includes loading a graft onto an adjustable filament loop that is coupled to an implant body. The adjustable filament loop can have at least one adjustable limb extending therefrom, and the implant body can have a shuttle filament disposed therethrough. Further, the adjustable limb can have a segment disposed in a hollow portion of the shuttle filament with a terminal end of the adjustable limb exiting the shuttle filament at a location that is more remote from an entry point of the segment into the shuttle filament. The method can further include pulling the shuttle filament, the implant body, the adjustable filament loop, and the graft, through a bone tunnel until the implant body exits the tunnel while at least a portion of the adjustable filament loop and the graft remain in the tunnel. Still further, the method can include orienting the implant body so that a bottom side of the implant body is facing the tunnel such that the adjustable filament loop is disposed substantially within the tunnel and the at least one adjustable limb is outside of the tunnel, adjacent to a top side of the implant body.
In some embodiments the method can further include applying tension to the at least one adjustable limb in a first direction, away from the implant body, and cutting the shuttle filament and the at least one adjustable limb so that the shuttle filament and the excess limb can be removed. The shuttle filament and the at least one adjustable limb can be cut at a variety of locations, but in some embodiments they can be cut at a location that is approximately between a location at which the terminal end of the adjustable limb enters the shuttle filament and a location at which the terminal end of the adjustable limb exits the shuttle filament. In some other embodiments the method can further include applying a first tension to the at least one adjustable limb in a first direction, away from the implant, applying a force to the shuttle filament in a second, opposite direction, toward the implant, thereby causing the shuttle filament to bunch, and then cutting the shuttle filament and the at least one adjustable limb at a location that is proximate to a location at which the terminal end of the adjustable limb exits the shuttle filament. The methods can also include removing the shuttle filament and the cut portion of the at least one adjustable limb from the surgical site.
This invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present invention. Further, to the extent that linear or circular dimensions are used in the description of the disclosed systems, devices, and methods, such dimensions are not intended to limit the types of shapes that can be used in conjunction with such systems, devices, and methods. A person skilled in the art will recognize that an equivalent to such linear and circular dimensions can easily be determined for any geometric shape. Sizes and shapes of the systems and devices, and the components thereof, can depend at least on the anatomy of the subject in which the systems and devices will be used, the size and shape of components with which the systems and devices will be used, and the methods and procedures in which the systems and devices will be used.
The figures provided herein are not necessarily to scale. Further, to the extent arrows are used to describe a direction a component can be tensioned or pulled, these arrows are illustrative and in no way limit the direction the respective component can be tensioned or pulled. A person skilled in the art will recognize other ways and directions for creating the desired tension or movement. Likewise, while in some embodiments movement of one component is described with respect to another, a person skilled in the art will recognize that other movements are possible. Additionally, a number of terms may be used throughout the disclosure interchangeably but will be understood by a person skilled in the art. By way of non-limiting example, the terms “suture” and “filament” may be used interchangeably.
The present disclosure generally relates to a surgical implant for use in surgical procedures such as soft tissue (e.g., ACL) repairs. One exemplary embodiment of such an implant 100 is illustrated in
A second filament 60, sometimes referred to herein as a shuttle suture or filament or a leading suture or filament, can be removably coupled to or otherwise associated with the body 10 and can be configured to help shuttle the body 10, and thus the first filament 40 and ligament graft associated therewith, into and at least partially through a bone tunnel. As shown, the second filament 60 can have a first limb 62 and a second limb 64 extending from opposed sides of one of the thru-holes 24. Each limb 62, 64 can include a receiving portion 66, 68 configured to receive respective portions of the first and second adjustable limbs 52, 54, thereby assisting in filament management, as well as providing a convenient way to help insure that any cutting of the first and second adjustable limbs 52, 54 is not to the detriment of the integrity of the self-locking knot 46, as discussed in greater detail below.
Optionally, a third filament 80, sometimes referred to herein as a trailing suture or filament, can be removably coupled to or otherwise associated with the body 10 and can be used in conjunction with the second filament 60 to assist in the placement of the body 10 with respect to the bone during a procedure. The third filament 80 can have a first limb 82 and a second limb 84 extending from opposed sides of one of the thru-holes 24.
A body 10 for use as a part of a surgical implant to fixate a ligament graft in bone is illustrated in
A person skilled in the art will recognize that the body 10 described herein is merely one example of a body that can be used in conjunction with the teachings provided herein. A body configured to be associated with a suture filament of the type described herein can have a variety of different shapes, sizes, and features, and can be made of a variety of different materials, depending, at least in part, on the other components with which it is used, such as the suture filament and the ligament graft, and the type of procedure in which it is used. Thus, while in one embodiment the body 10 is somewhat rectangular having curved ends, in other embodiments the body can be substantially tubular, among other shapes.
In one exemplary embodiment of the substantially rectangular body 10, the length L of the body is in the range of about 5 millimeters to about 30 millimeters, the width W is in the range of about 1 millimeter to about 10 millimeters, and the thickness T is in the range of about 0.25 millimeters to about 3 millimeters. In one exemplary embodiment, the length L can be about 12 millimeters, the width W can be about 4 millimeters, and the thickness T can be about 1.5 millimeters. Diameters of the thru-holes 24 can be in the range of about 0.5 millimeters to about 5 millimeters, and in one exemplary embodiment each can be about 2 millimeters. Although in the illustrated embodiment each of the thru-holes 24a, 24b, 24c, 24d has a substantially similar diameter, in other embodiments some of the thru-holes can have different diameters, such as thru-holes 24a′, 24b′, 24c′, 24d′ of body 10′ illustrated in
In exemplary embodiments the body 10 can be made from a stainless steel or titanium, but any number of polymers, metals, or other biocompatible materials in general can be used to form the body. Some non-limiting examples of biocompatible materials suitable for forming the body include a polyether ether ketone (PEEK), bioabsorbable elastomers, copolymers such as polylactic acid-polyglycolic acid (PLA-PGA), and bioabsorbable polymers such as polylactic acid. The implant can also be formed of absorbable and non-absorbable materials. Other exemplary embodiments of a body or cortical button that can be used in conjunction with the teachings herein are described at least in U.S. Pat. No. 5,306,301 of Graf et al., the content of which is incorporated by reference herein in its entirety.
The first filament 40 can be associated with the body 10, 10′ to form a surgical implant 100, 100′ in a variety of ways. As shown in
The adjustable limbs 52, 54 can extend distally beyond the opening, as shown in
Any number of coils can be formed from the first and second limbs 52, 54, including a single coil from each, and the number of coils formed in the first limb 52 does not have to be the same number of coils formed in the second limb 54. In some exemplary embodiments, three or four coils can be formed in one or both of the limbs. Further, the limbs used to form the coils can be passed through any number of thru-holes formed in the body 10′. The first limb 52 does not need to pass through the same thru-holes through which the second limb 54 passes, and likewise, when multiple coils are formed in one limb, that limb does not have to be passed through the same thru-holes to form each coil. A person skilled in the art will recognize a number of configurations between the filament and thru-holes that can be used to form one or more coils in the filament limbs before disposing terminal ends of the limbs through a collapsible opening of a knot to create a self-locking knot.
The configuration of the body 10, 10′ and the first filament 40 can allow for selective movement of the coils 42a, 42b, 42c, 42d, and thus grafts 102, 104 associated therewith, as illustrated in
The first filament 40 can be an elongate filament, and a variety of different types of suture filaments can be used, including but not limited to a cannulated filament, a braided filament, and a mono filament. The type, size, and strength of the filament can depend, at least in part, on the other materials of the implant, including the material(s) of the cortical button and the ligament graft, the tissue, bone, and related tunnels through which it will be passed, and the type of procedure in which it is used. In one exemplary embodiment the filament is a #0 filament (about 26 gauge to about 27 gauge), such as an Orthocord™ filament that is commercially available from DePuy Mitek, LLC., 325 Paramount Drive, Raynham, Mass. 02767, or an Ethibond™ filament that is commercially available from Ethicon, Inc., Route 22 West, Somerville, N.J. 08876. The thickness of the filament should provide strength in the connection but at the same time minimize the trauma caused to tissue through which it passes. In some embodiments the filament can have a size in the range of about a #5 filament (about 20 gauge to about 21 gauge) to about a #3-0 filament (about 29 gauge to about 32 gauge). Orthocord™ suture is approximately fifty-five to sixty-five percent PDS™ polydioxanone, which is bioabsorbable, and the remaining thirty-five to forty-five percent ultra high molecular weight polyethylene, while Ethibond™ suture is primarily high strength polyester. The amount and type of bioabsorbable material, if any, utilized in the filaments of the present disclosure is primarily a matter of surgeon preference for the particular surgical procedure to be performed. In some exemplary embodiments, a length of the filament can be in the range of about 0.2 meters to about 5 meters, and in one embodiment it has a length of about 1.5 meters.
The first filament 40 can be delivered to a surgeon for use pre-attached to the cortical button. Alternatively, the formation of the loop 42 can be performed by a surgeon prior to inserting the implant 100, 100′ into a bone tunnel. The surgeon can use any of the techniques described herein, or otherwise known to those skilled in the art to couple to first filament 40 to a cortical button.
Openings 70, 72 and 74, 76 can be formed in the shuttle suture 60 to access the hollow portions. As shown, second openings 72, 76, through which limbs 52, 54 can exit the receiving portions 66, 68, can be located more remote from the body 10′ than first openings 70, 74, through which the limbs 52, 54 can enter the receiving portions 66, 68. Openings 70, 72 and 74, 76 can be located at any distance proximal of the body 10′. For example, a vertical distance R between a top surface 20′ of the body 10′ and the first openings 70, 74 can be approximately in the range of about 5 millimeters to about 50 millimeters, and in one exemplary embodiment the distance R can be about 10 millimeters. As the vertical distance increases, it can be easier for the shuttle suture 60 to be removed from the body 10′ once a procedure is completed and the shuttle suture 60 is no longer needed. Further, a length H of the hollow portion can be approximately in the range of about 10 millimeters to about 100 millimeters, and in one exemplary embodiment the length H can be about 20 millimeters. The length H of the hollow portion can approximately reflect the length of the limbs 52, 54 that remain after a portion of the limbs 52, 54 are cut and removed, as discussed below.
The limbs 52, 54 can be associated with the receiving portions 66, 68 of the shuttle suture 60 by extending terminal ends 52t, 54t of the limbs 52, 54 from the knot 46 (shown in its un-collapsed, Lark's Head configuration 48 in
The shuttle suture 60 can be an elongate filament of a variety of types, including but not limited to a cannulated filament and a braided filament. The type, size, and strength of the filament can depend, at least in part, on the other materials of the implant, such as the cortical button and the first, graft-holding filament, and the type of procedure in which it is used. The shuttle suture 60 can be made from a wide variety of biocompatible flexible materials, including a flexible polymer. In one embodiment the shuttle suture 60 is made of a polymeric material having a core disposed therein. As described above, at least a portion of the core can be removed to provide one or more receiving portions 66, 68. In another embodiment, the shuttle suture is a flexible filament, such as a braided suture, for example Ethibond™ #5 filament (about 20 gauge to about 21 gauge). In some exemplary embodiments, the shuttle suture can be a #5 braided, flexible filament (about 20 gauge to about 21 gauge) and can be made of ultra high molecular weight polyethylene with two polyester racers. The pick count of the braid can adjusted as desired. For example, the pick count can be approximately in the range of about 30 picks per 2.54 centimeters to about 80 picks per 2.54 centimeters, and in one instance the pick count can be about 36 picks per 2.54 centimeters. A person skilled in the art will recognize that other pick counts can be used depending, at least in part, on the size of the filament to be received by the shuttle suture, the type of tissue through which the shuttle suture will be disposed, and the various desired properties of the overall construct, such as the ease of sliding a filament within the shuttle suture and/or the amount of bunching that is desired in the shuttle suture. A length of the shuttle suture can be in the range of about 0.1 meters to about 1.5 meters, and in one embodiment the length is about 1 meter.
Although the illustrated embodiment shows the loop 42 formed by the first filament 40 having two limbs 52, 54 extending from the knot 46 (i.e., the Lark's Head knot configuration 48), in some embodiments, a single adjustable limb can extend from the knot. Accordingly, the shuttle suture 60 can have a single receiving portion that is hollow, and a portion of the single adjustable limb can be disposed in the hollow portion. Alternatively, if two adjustable limbs are included, both can be disposed in the same receiving portion. In other embodiments, three or more adjustable limbs can extend from the loop formed by the first filament, and the shuttle suture can be configured to receive any number of the limbs, including more than two, without departing from the spirit of the present disclosure.
The trailing suture 80 can optionally be included to further assist passing the implant 100′ through a bone tunnel, as described in further detail below. As shown, the trailing suture 80 can be disposed through the thru-hole 24d and around a trailing end 18′ of the body 10′ such that opposed first and second limbs 82, 84 extend proximally from the body 10′. Similar to other filaments of the present disclosure, the trailing suture can be an elongate filament of a variety of types, including but not limited to a cannulated filament, a braided filament, and a mono filament. The type, size, and strength of the filament can depend, at least in part, on the other materials of the implant, such as the cortical button, and the type of procedure in which it is used. In one exemplary embodiment the trailing suture is formed from a #5 filament (about 20 gauge to about 21 gauge). In some embodiments the filament can have a size in the range of about a #2-0 filament (about 28 gauge) and about a #5 filament (about 20 gauge to about 21 gauge). A length of the filament can be in the range of about 0.1 meters to about 1.5 meters, and in one embodiment the length is about 1 meter.
Both the shuttle or leading filament 60 and the trailing filament 80 can be removably coupled to the body 10′. In some embodiments, the action of associating either or both of the leading filament 60 and the trailing filament 80 with the body 10′ by passing the filaments through thru-holes 24′ of the body 10′ can be performed by a surgeon during a procedure. In some other embodiments, the body 10′ can come pre-loaded with either or both of the leading filament 60 and the trailing filament 80 already passed through the respective thru-holes 24′ of the body 10′. The filaments 60, 80 may have a loose knot formed therein to help maintain their location in the thru-holes 24′ during shipping, and then the knot can be undone once removed from the packaging. Other techniques use to maintain an approximate location of a filament with respect to a cortical button during shipping can also be used in conjunction with the body 10′, leading filament 60, and trailing filament 80 without departing from the spirit of the present disclosure.
Although the embodiment illustrated in
Different exemplary features associated with performing soft tissue repair (e.g., an ACL repair) using a surgical implant like those described herein are illustrated in
The implant 100′″ illustrated in
A surgeon can begin the procedure by preparing the knee 1000 and soft tissue tendon grafts using techniques known by those skilled in the art. As shown in
As shown in
A counterforce can be applied to the graft 102′ so that the entire construct is not fully inserted into the bone tunnel 1002. This allows for the graft 102′ to be used to help orient the body or cortical button 10′″ or the implant 100′″ with respect to the bone tunnel 1002 if desired. Further, as the button 10′″ and loop 42′ enter the bone tunnel 1002, care can be taken to prevent the button 10′″ from becoming wrapped in one or more coils of the loop 42′. Once the implant 100′″ enters the bone tunnel 1002, optical devices, such as arthroscopes, can be used to continue to monitor it. If any one of the coils of the loop 42′ undesirably wraps around the button 10′″, the surgeon can use instruments to unwrap the coils from the button and/or the surgeon can selectively apply tension to any of the leading filament 60′, the trailing filament 80′, and the graft 102′ to manipulate and untangle the button 10′″ from the coil(s).
Continued application of the force in the approximate direction J can pull the cortical button 10′″ through the passing channel 1007. As the button 10′″ passes through the passing channel 1007 and crests while passing out of the channel, i.e., when a substantial portion of the button 10′″ is disposed outside of the channel, as shown in
A variety of techniques can be used to flip or reorient the cortical button 10′″, but in the illustrated embodiment, shown in
Once the button 10′″ is disposed at its desired location, tension can be applied to the adjustable limb 53′ to adjust a circumference of the loop 42′, thereby moving the graft 102′ within the bone tunnel 1002 to a desired location. The circumference of the loop 42′, and thus the circumferences of the coils represented by the loop 42′, can be adjusted using a number of different techniques, including those described herein. In one exemplary embodiment, illustrated in
Once the implant 100′″ and graft 102′ are positioned in their desired locations, excess filaments can be removed, including portions of the adjustable limb 53′, the leading filament 60′, and the trailing filament 80′. When cutting excess filament, such as from the adjustable limb 53′, care is generally taken to ensure that enough material remains so as not to negatively impact the integrity of the knot 46′. The configuration of the implant 100′″, and in particular having a leading filament 60′ having a receiving portion 66′ for receiving the adjustable limb 53′, can help in this regard.
As shown in
In other embodiments, a surgeon can select a different location to cut the leading filament 60′ and the adjustable limb 53′. For example, a force in an approximate opposite direction T may not be supplied and the surgeon may cut the shuttle suture at a location that is between the first opening 70′ and the second opening 72′ of the leading filament 60′, or at a location that is proximate to the first opening 70′. A person skilled in the art, in view of the present disclosure, will recognize a variety of other locations at which the leading filament 60′ and associated adjustable limb 53′ can be cut to still leave behind a desired length of the adjustable limb 53′ without departing from the spirit of the present disclosure. Likewise, a person skilled in the art, in view of the present disclosure, will recognize a variety of other techniques that can be used to arrive at a desired location at which the leading filament 60′ and associated adjustable limb 53′ can be cut to still allow for a desired length of the adjustable limb 53′ to remain after the cutting is performed without departing from the spirit of the present disclosure.
In one exemplary embodiment, tension can be alternately applied in an approximate direction P to the adjustable filament tails 52″, 54″ to advance the grafts 102″, 104″ in increments of approximately 1 centimeter. Alternatively, the grafts 102″, 104″ can be advanced by using a configuration in which the adjustable filament tails 52″, 54″ are tied together and held in one hand while tension in the approximate direction Q is applied to the grafts 102″, 104″ by another hand. The surgeon can then alternate between pronation and supination to tighten the adjustable filament tails 52″, 54″, and thereby the coils of the loops 42a″, 42b″, which in turn advance the grafts 102″, 104″ proximally through the femoral tunnel 1004.
The grafts 102″, 104″ can be advanced to a desired location, for example up to the passing channel 1007 of the femoral tunnel 1004. When a graft reaches the passing channel 1007, typically the resistance to tightening of the coils of the loops noticeably increases. In some embodiments, such as that illustrated in
The ability to control two independently tensioned ligament grafts in a single tunnel using a single cortical button is an improvement over existing techniques for ACL repairs. In existing methods for performing ACL repairs, a cortical button having filament associated therewith can only control a single bundle of ligament graft. Thus, if independent movement of multiple ligaments is needed, each ligament is typically associated with its own cortical button. Some surgeons use a double-tunnel technique to implant two ligaments, thus fixing each graft bundle in separate tunnels. Double-tunnel techniques likewise require one button per bundle. Thus, the methods described and resulting from disclosures herein represent improved ACL repair techniques because they allow for two ligament bundles to be independently moved using a single button, and doing so in a single tunnel. This results in procedures that have a reduced risk of complications and is generally less complex than existing procedures. Further, by disposing the adjustable limbs within a leading or shuttle filament used to manipulate the cortical button to a desired location, it can be easier to manage and control the filaments associated with the implant. Such a configuration also provides for an easy way to establish a desired length of the limb that is left behind so that the integrity of the knot of the loop is not compromised. A person skilled in the art will recognize that the disclosures pertaining to independently controlling two filament loops, and managing filaments by disposing them within a shuttle filament can be broadly applied to a variety of implant designs and surgical procedures, and can even be applied to non-medical fields without departing from the spirit of the present disclosure.
One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. By way of non-limiting example, the exemplary ACL repair methods described herein with respect to
The present application is a divisional of and claims priority to U.S. patent application Ser. No. 14/103,167, filed Dec. 11, 2013, and entitled “Implant Having Filament Limbs of an Adjustable Loop Disposed in a Shuttle Suture,” the contents of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2600395 | Domoj et al. | Jun 1952 | A |
4093292 | Marcet et al. | Jun 1978 | A |
4105349 | Kupperman et al. | Aug 1978 | A |
4133604 | Fuller | Jan 1979 | A |
4186921 | Fox | Feb 1980 | A |
4233917 | Carnaby | Nov 1980 | A |
4255836 | Dunahoo | Mar 1981 | A |
4257309 | Dunahoo | Mar 1981 | A |
4319428 | Fox | Mar 1982 | A |
4469101 | Coleman et al. | Sep 1984 | A |
4510934 | Batra | Apr 1985 | A |
4526125 | Bain, Jr. | Jul 1985 | A |
4527564 | Eguchi et al. | Jul 1985 | A |
4582165 | Latini | Apr 1986 | A |
4604821 | Moser | Aug 1986 | A |
4705040 | Mueller et al. | Nov 1987 | A |
4723634 | Fisk | Feb 1988 | A |
4750492 | Jacobs | Jun 1988 | A |
4773910 | Chen et al. | Sep 1988 | A |
4781191 | Thompson | Nov 1988 | A |
4854138 | Charland | Aug 1989 | A |
4890363 | Cross | Jan 1990 | A |
4910834 | Minkler | Mar 1990 | A |
4946377 | Kovach | Aug 1990 | A |
4962929 | Melton, Jr. | Oct 1990 | A |
4971075 | Lee | Nov 1990 | A |
5062344 | Gerker | Nov 1991 | A |
5074291 | Carter | Dec 1991 | A |
5083875 | Cedrone | Jan 1992 | A |
5139520 | Rosenberg | Aug 1992 | A |
5149329 | Richardson | Sep 1992 | A |
5150766 | Bell | Sep 1992 | A |
5168605 | Bartlett | Dec 1992 | A |
5178629 | Kammerer | Jan 1993 | A |
5219359 | McQuilkin et al. | Jun 1993 | A |
5269783 | Sander | Dec 1993 | A |
5306290 | Martins et al. | Apr 1994 | A |
5306301 | Graf et al. | Apr 1994 | A |
5374268 | Sander | Dec 1994 | A |
5374269 | Rosenberg | Dec 1994 | A |
5451203 | Lamb | Sep 1995 | A |
5505735 | Li | Apr 1996 | A |
5531759 | Kensey et al. | Jul 1996 | A |
5540703 | Barker, Jr. et al. | Jul 1996 | A |
5573286 | Rogozinski | Nov 1996 | A |
5575819 | Amis | Nov 1996 | A |
5628756 | Barker | May 1997 | A |
5649541 | Stuckey | Jul 1997 | A |
5667528 | Colligan | Sep 1997 | A |
5693060 | Martin | Dec 1997 | A |
5707373 | Sevrain et al. | Jan 1998 | A |
5769894 | Ferragamo | Jun 1998 | A |
5778904 | Elsner | Jul 1998 | A |
5921986 | Bonutti | Jul 1999 | A |
5928267 | Bonutti et al. | Jul 1999 | A |
5984926 | Jones | Nov 1999 | A |
5989252 | Fumex | Nov 1999 | A |
6009882 | Schine et al. | Jan 2000 | A |
6030007 | Bassily et al. | Feb 2000 | A |
6045551 | Bonutti | Apr 2000 | A |
6056752 | Roger | May 2000 | A |
6076532 | Thomas et al. | Jun 2000 | A |
6117160 | Bonutti | Sep 2000 | A |
6143029 | Rippstein | Nov 2000 | A |
6203572 | Johnson et al. | Mar 2001 | B1 |
6238395 | Bonutti | May 2001 | B1 |
6258091 | Sevrain et al. | Jul 2001 | B1 |
6293961 | Schwartz et al. | Sep 2001 | B2 |
6296659 | Foerster | Oct 2001 | B1 |
6306159 | Schwartz | Oct 2001 | B1 |
6319271 | Schwartz et al. | Nov 2001 | B1 |
6342060 | Adams | Jan 2002 | B1 |
6418576 | Starkweather | Jul 2002 | B1 |
6453974 | Lai et al. | Sep 2002 | B1 |
6503267 | Bonutti et al. | Jan 2003 | B2 |
6517578 | Hein | Feb 2003 | B2 |
6527795 | Lizardi | Mar 2003 | B1 |
6533802 | Bojarski et al. | Mar 2003 | B2 |
6558389 | Clark et al. | May 2003 | B2 |
6589244 | Sevrain et al. | Jul 2003 | B1 |
6592609 | Bonutti | Jul 2003 | B1 |
6599319 | Knudsen et al. | Jul 2003 | B2 |
6602290 | Esnouf et al. | Aug 2003 | B2 |
6638279 | Bonutti | Oct 2003 | B2 |
6972027 | Fallin et al. | Dec 2005 | B2 |
6997480 | Legrand | Feb 2006 | B2 |
6997940 | Bonutti | Feb 2006 | B2 |
7033380 | Schwartz et al. | Apr 2006 | B2 |
7076845 | Tylaska et al. | Jul 2006 | B2 |
7150757 | Fallin et al. | Dec 2006 | B2 |
7235091 | Thornes | Jun 2007 | B2 |
7285124 | Foerster | Oct 2007 | B2 |
7306417 | Dorstewitz | Dec 2007 | B2 |
7390332 | Selvitelli et al. | Jun 2008 | B2 |
7407512 | Bojarski et al. | Aug 2008 | B2 |
7442210 | Segal et al. | Oct 2008 | B2 |
7481825 | Bonutti | Jan 2009 | B2 |
7500990 | Whelan | Mar 2009 | B2 |
7566339 | Fallin et al. | Jul 2009 | B2 |
7594923 | Fallin et al. | Sep 2009 | B2 |
7601165 | Stone | Oct 2009 | B2 |
7628795 | Karwoski et al. | Dec 2009 | B2 |
7641694 | Goble et al. | Jan 2010 | B1 |
7654321 | Zazovsky et al. | Feb 2010 | B2 |
7658751 | Stone et al. | Feb 2010 | B2 |
7682374 | Foerster et al. | Mar 2010 | B2 |
7686838 | Wolf et al. | Mar 2010 | B2 |
7703372 | Shakespeare | Apr 2010 | B1 |
7722644 | Fallin et al. | May 2010 | B2 |
7749250 | Stone et al. | Jul 2010 | B2 |
7776039 | Bernstein et al. | Aug 2010 | B2 |
7806909 | Fallin et al. | Oct 2010 | B2 |
7845669 | Yeh et al. | Dec 2010 | B2 |
7846181 | Schwartz et al. | Dec 2010 | B2 |
7857830 | Stone et al. | Dec 2010 | B2 |
7875057 | Cook et al. | Jan 2011 | B2 |
7875058 | Holmes, Jr. | Jan 2011 | B2 |
7887551 | Bojarski et al. | Feb 2011 | B2 |
7892238 | DiPoto et al. | Feb 2011 | B2 |
7892256 | Grafton et al. | Feb 2011 | B2 |
7901431 | Shumas | Mar 2011 | B2 |
7905903 | Stone et al. | Mar 2011 | B2 |
7959650 | Kaiser et al. | Jun 2011 | B2 |
8012171 | Schmieding | Sep 2011 | B2 |
8088130 | Kaiser et al. | Jan 2012 | B2 |
8118836 | Denham et al. | Feb 2012 | B2 |
8127652 | Hennings et al. | Mar 2012 | B1 |
8128658 | Kaiser et al. | Mar 2012 | B2 |
8136438 | Shakespeare | Mar 2012 | B2 |
8137382 | Denham et al. | Mar 2012 | B2 |
8147514 | Bonutti | Apr 2012 | B2 |
8202298 | Cook et al. | Jun 2012 | B2 |
8221455 | Shumas et al. | Jul 2012 | B2 |
8231654 | Kaiser et al. | Jul 2012 | B2 |
8257394 | Saadat et al. | Sep 2012 | B2 |
8298271 | Jacene et al. | Oct 2012 | B2 |
8366744 | Bojarski et al. | Feb 2013 | B2 |
8388655 | Fallin et al. | Mar 2013 | B2 |
8398678 | Baker et al. | Mar 2013 | B2 |
8439976 | Albertorio et al. | May 2013 | B2 |
8460379 | Albertorio et al. | Jun 2013 | B2 |
8475534 | Karnes et al. | Jul 2013 | B2 |
8512376 | Thornes | Aug 2013 | B2 |
8523943 | Hart | Sep 2013 | B2 |
8535313 | Masson | Sep 2013 | B1 |
8591578 | Albertorio et al. | Nov 2013 | B2 |
8617185 | Bonutti et al. | Dec 2013 | B2 |
8628573 | Roller et al. | Jan 2014 | B2 |
8753375 | Albertorio | Jun 2014 | B2 |
8790370 | Spenciner et al. | Jul 2014 | B2 |
8808329 | Bonutti | Aug 2014 | B2 |
8864797 | Justin et al. | Oct 2014 | B2 |
8876900 | Guederian et al. | Nov 2014 | B2 |
8882816 | Kartalian et al. | Nov 2014 | B2 |
8888815 | Holmes, Jr. | Nov 2014 | B2 |
8936621 | Denham | Jan 2015 | B2 |
8961575 | Choinski | Feb 2015 | B2 |
8998904 | Zeetser et al. | Apr 2015 | B2 |
9005245 | Thornes et al. | Apr 2015 | B2 |
9072510 | Thornes et al. | Jul 2015 | B2 |
10405968 | Gustafson et al. | Sep 2019 | B2 |
20020029066 | Foerster | Mar 2002 | A1 |
20030005557 | Renn | Jan 2003 | A1 |
20040153153 | Elson et al. | Aug 2004 | A1 |
20060064126 | Fallin et al. | Mar 2006 | A1 |
20060089646 | Bonutti | Apr 2006 | A1 |
20060190042 | Stone et al. | Aug 2006 | A1 |
20080027446 | Stone et al. | Jan 2008 | A1 |
20080046009 | Albertorio et al. | Feb 2008 | A1 |
20080287991 | Fromm | Nov 2008 | A1 |
20090082805 | Kaiser et al. | Mar 2009 | A1 |
20090182335 | Struhl | Jul 2009 | A1 |
20090234377 | Mahlin et al. | Sep 2009 | A1 |
20090281568 | Cendan et al. | Nov 2009 | A1 |
20090312776 | Kaiser et al. | Dec 2009 | A1 |
20090312792 | Fallin et al. | Dec 2009 | A1 |
20100069926 | Goble et al. | Mar 2010 | A1 |
20100106194 | Bonutti et al. | Apr 2010 | A1 |
20100249809 | Singhatat et al. | Sep 2010 | A1 |
20100256677 | Albertorio et al. | Oct 2010 | A1 |
20100268273 | Albertorio et al. | Oct 2010 | A1 |
20100292733 | Hendricksen et al. | Nov 2010 | A1 |
20100305585 | Fallin et al. | Dec 2010 | A1 |
20100318126 | Fallin et al. | Dec 2010 | A1 |
20110022061 | Orphanos et al. | Jan 2011 | A1 |
20110022083 | DiMatteo et al. | Jan 2011 | A1 |
20110060375 | Bonutti | Mar 2011 | A1 |
20110077667 | Singhatat et al. | Mar 2011 | A1 |
20110098727 | Kaiser et al. | Apr 2011 | A1 |
20110144699 | Fallin et al. | Jun 2011 | A1 |
20110152927 | Deng et al. | Jun 2011 | A1 |
20110160749 | Gordon et al. | Jun 2011 | A1 |
20110160856 | Sinnott et al. | Jun 2011 | A1 |
20110190815 | Saliman | Aug 2011 | A1 |
20110208240 | Stone et al. | Aug 2011 | A1 |
20110218625 | Berelsman et al. | Sep 2011 | A1 |
20110238111 | Frank | Sep 2011 | A1 |
20110276137 | Seedhom et al. | Nov 2011 | A1 |
20110301708 | Stone et al. | Dec 2011 | A1 |
20120046693 | Denham | Feb 2012 | A1 |
20120046747 | Justin et al. | Feb 2012 | A1 |
20120053630 | Denham et al. | Mar 2012 | A1 |
20120059416 | Justin | Mar 2012 | A1 |
20120059468 | Mattern et al. | Mar 2012 | A1 |
20120065731 | Justin | Mar 2012 | A1 |
20120065732 | Roller et al. | Mar 2012 | A1 |
20120109129 | Bernstein | May 2012 | A1 |
20120109194 | Miller et al. | May 2012 | A1 |
20120116452 | Stone et al. | May 2012 | A1 |
20120123474 | Zajac et al. | May 2012 | A1 |
20120123541 | Albertorio et al. | May 2012 | A1 |
20120130424 | Sengun | May 2012 | A1 |
20120150203 | Brady et al. | Jun 2012 | A1 |
20120150297 | Denham et al. | Jun 2012 | A1 |
20120158051 | Foerster | Jun 2012 | A1 |
20120158053 | Paulos | Jun 2012 | A1 |
20120165867 | Denham et al. | Jun 2012 | A1 |
20120165938 | Denham et al. | Jun 2012 | A1 |
20120290002 | Astorino | Nov 2012 | A1 |
20120290004 | Lombardo et al. | Nov 2012 | A1 |
20120290006 | Collins et al. | Nov 2012 | A1 |
20120296375 | Thal | Nov 2012 | A1 |
20120303059 | Saadat et al. | Nov 2012 | A1 |
20120310279 | Sikora et al. | Dec 2012 | A1 |
20130023942 | Wyman et al. | Jan 2013 | A1 |
20130035722 | McDevitt et al. | Feb 2013 | A1 |
20130066371 | Rogers et al. | Mar 2013 | A1 |
20130085568 | Smith et al. | Apr 2013 | A1 |
20130096612 | Zajac et al. | Apr 2013 | A1 |
20130123810 | Brown et al. | May 2013 | A1 |
20130123841 | Lyon | May 2013 | A1 |
20130138150 | Baker et al. | May 2013 | A1 |
20130165972 | Sullivan | Jun 2013 | A1 |
20130165973 | Fallin et al. | Jun 2013 | A1 |
20130172944 | Fritzinger et al. | Jul 2013 | A1 |
20130197576 | Catania et al. | Aug 2013 | A1 |
20130197577 | Wolf et al. | Aug 2013 | A1 |
20130197578 | Gregoire et al. | Aug 2013 | A1 |
20130197579 | Foerster et al. | Aug 2013 | A1 |
20130197580 | Perriello et al. | Aug 2013 | A1 |
20130268000 | Harner et al. | Oct 2013 | A1 |
20130268073 | Albertorio et al. | Oct 2013 | A1 |
20130296931 | Sengun | Nov 2013 | A1 |
20130317544 | Ferguson et al. | Nov 2013 | A1 |
20140074239 | Albertorio et al. | Mar 2014 | A1 |
20140081399 | Roller et al. | Mar 2014 | A1 |
20140142627 | Hendricksen et al. | May 2014 | A1 |
20140257346 | Sengun et al. | Sep 2014 | A1 |
20140330312 | Spenciner et al. | Nov 2014 | A1 |
20150073477 | Holmes, Jr. | Mar 2015 | A1 |
20150157449 | Gustafson et al. | Jun 2015 | A1 |
Number | Date | Country |
---|---|---|
203220425 | Oct 2013 | CN |
2 238 944 | Oct 2010 | EP |
2581047 | Apr 2013 | EP |
2743294 | Jul 1997 | FR |
2001-198147 | Jul 2001 | JP |
2013-233434 | Nov 2013 | JP |
92006648 | Apr 1992 | WO |
Entry |
---|
Extended European Search Report for Application No. 14197234.9, dated May 15, 2015 (7 pages). |
Japanese Office Action for Application No. 2014-249794, dated Sep. 4, 2018 (13 Pages). |
U.S. Appl. No. 14/103,167, filed Dec. 11, 2013, Implant Having Filament Limbs of an Adjust Loop Disposed in a Shuttle Suture. |
Chinese Office Action for Application No. 201410764556.8, dated Feb. 24, 2018 (8 pages). |
Number | Date | Country | |
---|---|---|---|
20190358022 A1 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14103167 | Dec 2013 | US |
Child | 16533986 | US |